Awards and Recognition

Wanbury Limited announced that its two API manufacturing facilities have received significant awards for employee practices and safety performance:

  • Patalganga, Maharashtra API Manufacturing Facility: Received the "Certificate of Excellence" from the National Safety Council for safety performance. This marks the third consecutive year the facility has received this recognition.
  • Tanuku, Andhra Pradesh API Manufacturing Facility: Received the "Best Employer Award" from the Andhra Pradesh State Government, recognizing its employee practices and workplace culture.

Management Commentary

Mr. Mohan Rayana, Director of Wanbury Limited, stated: "Our people and their safety are at the heart of everything we do. These awards for our Tanuku and Patalganga teams recognise their dedication to a safe, compliant and rewarding workplace. We will keep raising the bar on employee welfare and safety across all our sites."

Company Business Overview

Wanbury Limited, established in 1988 and listed on both NSE (Code: WANBURY) and BSE (Code: 524212), has:

  • API Business: Strong presence in global API markets with exports to over 50 countries. Both Tanuku (Andhra Pradesh) and Patalganga (Maharashtra) facilities are USFDA & EUGMP approved.
  • API Product Portfolio: Includes Antidiabetic, Antidepressant, Pain management, Antihistamine, Anti-inflammatory, and various other products in pipeline. Clients include leading global generic players.
  • Formulations Business: Pan-India presence across major therapeutic categories including cough and cold solutions, gynecology, orthopedics, nutraceuticals, gastrointestinal, anti-inflammatory, and analgesics.

Compliance and Standards

The company emphasized its commitment to upholding high environment, health and safety (EHS) standards while complying with Good Manufacturing Practice (GMP) norms.

Forward-Looking Statements Disclaimer

The document contains cautionary language stating that it may contain forward-looking statements reflecting management's current views and estimates, with actual results potentially differing due to factors including general economic conditions, foreign exchange fluctuation, pricing pressures, competition, and regulatory developments.